摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methoxy-1,3,2-oxazaphosphinane | 865434-41-9

中文名称
——
中文别名
——
英文名称
2-methoxy-1,3,2-oxazaphosphinane
英文别名
2-Methoxy-1,3,2-oxazaphosphinane
2-methoxy-1,3,2-oxazaphosphinane化学式
CAS
865434-41-9
化学式
C4H10NO2P
mdl
——
分子量
135.103
InChiKey
GZIDXJOBBISVNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-methoxy-1,3,2-oxazaphosphinanemethyl 2-[(2-bromoacetyl)amino]acetate 为溶剂, 反应 1.0h, 以47%的产率得到N-[(2-oxo-1,3,2λ5-oxazaphosphinan-2-yl)acetyl]glycine methyl ester
    参考文献:
    名称:
    磷酸乙酸衍生物的 1,3,2-Oxazaphosphinane 类似物:合成和性质
    摘要:
    2-AlkO-1,3,2-氧氮杂膦与烷基 N-卤代乙酰氨基或 N-氯甲基-N-甲氧基羰基氨基羧酸盐的反应主要产生具有保留 (Alk = Me) 和开环 (Alk = Et) 的产物。在水溶液中,带有 N-异丙基的环状产物是稳定的,而其余的则发生水解,环的 PN 键断裂。合成了磷酰乙酰胺和磷酰乙酰肼的氧氮杂膦类似物。
    DOI:
    10.1007/s11172-006-0167-5
点击查看最新优质反应信息

文献信息

  • Phosphorus-containing derivatives of L-aspartic and L-glutamic acids
    作者:A. E. Shipov、G. K. Genkina、E. I. Goryunov、I. B. Goryunova、P. V. Petrovskii
    DOI:10.1007/s11172-010-0054-y
    日期:2010.1
    Phosphorylureas (including those with the 1,3,2-oxazaphosphinane ring) containing L-aspartate and L-glutamate fragments, as well as 1,3,2-oxazaphosphinane derivatives of phos-phorylacetic acid with an L-aspartate fragment and of phosphamide with an L-glutamate fragment, were obtained in a search for structural analogs of aspartate transcarbamoylase and glutamate carboxypeptidase inhibitors.
    含有 L-天冬氨酸L-谷氨酸片段的磷酸(包括具有 1,3,2-氧氮杂膦环的那些),以及带有 L-天冬氨酸片段的磷酸乙酸酰胺的 1,3,2-氧氮膦衍生物在寻找天冬氨酸甲酰酶和谷酸羧肽酶抑制剂的结构类似物时,获得了带有 L-谷氨酸片段的 L-谷氨酸片段。
  • Arbuzov rearrangement in the 1,3,2-oxazaphosphinane series
    作者:A. E. Shipov、G. K. Genkina、P. V. Petrovskii、T. A. Mastryukova
    DOI:10.1007/s11172-005-0061-6
    日期:2004.9
    Reactions of 2-alkoxy-1,3,2-oxazaphosphinanes (including 3-alkyl derivatives) with methyl and ethyl bromoacetates give two types of Arbuzov rearrangement products (cyclic and acyclic ones). The ratio between their yields is virtually independent of the nature of the substituent in position 3 of the starting reagent, being mainly determined by the nature of the substituent in the phosphorus bound alkoxy
    2-烷氧基-1,3,2-氧氮杂膦(包括 3-烷基衍生物)与溴乙酸甲酯乙酯的反应产生两种类型的 Arbuzov 重排产物(环状和非环状产物)。它们的产率之比实际上与起始试剂 3 位取代基的性质无关,主要由键合烷氧基中取代基的性质决定,范围为 96:4 至 2:98。 无环产物可以转换成循环的。
查看更多

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (S)-2-Chloro-4-isobutyl-[1,3,2]oxazaphospholidine 2-sulfide (SCRP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-Chlor-1-(β-chlorethylamino)-1,3,2-azaoxaphosphorinan (SCSP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-[4-(2-Piperidin-1-yl-ethyl)-piperazin-1-yl]-[1,3,2]oxazaphosphinane 2-oxide (5-tert-Butyl-3-phenyl-[1,3,2]oxazaphosphinan-2-yl)-dimethyl-amine 4-Hydroperoxyisophosphamid-6-14C (E)-3-tert-butyl-6,6-dimethyl-2-oxo-[2'-((E)-2-butenyloxy)-1'-butenyl]-1,3,2-oxazaphosphorinane trichloroethyl cyclophosphoramidate 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 2(S)--3-<(S)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-1-methyl-propoxy)-[1,3,2]oxazaphosphinane 2-sulfide 2-hexadecyloxy-3-methyl-[1,3,2]oxazaphosphinane 2-oxide cis-4-Hydroperoxytrofosfamide 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine,N,N-diethyltetrahydro-3-(phenylmethyl)- 3-sec-Butyl-2-(2-chloro-1-methyl-ethoxy)-[1,3,2]oxazaphosphinane 2-sulfide cis-2-methoxy-2-thio-5-tert-butyl-1,3,2-oxazaphosphorinane 3,7,10-trimethyl-1-phenylgermatrane 2-{(2-Chloro-ethyl)-[3-(2-chloro-ethyl)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl]-amino}-ethanol 3-benzyl-2-chloro-[1,3,2]oxazaphosphinane 2-(O,O-Di-n-propyl-phosphordithiomethylen)-2-methyl-1,3-oxazolidin cis-2,3-diphenyl-2-oxo-5-tert-butyl-1,3,2λ5-oxazaphosphorinane 2-ethoxy-[1,3,2]oxazaphosphinane 2-oxide 1-Acetyl-2-diaethylamino-1,3,2-azaoxaphosphorinan 1,5-dioxa-2,6-dioxo-2,4,4,6,8,8-hexakis(pyrrolidino)cyclotetraphosphadiazadiene (2,4-dimethyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-3-yl)-phosphonous acid bis-diethylamide 2,6,6,9,12,12-hexamethyl-3,10-diphenyl-1,8-dioxa-4,11-dithia-2,9-diaza-dispiro[4.1.4.1]dodecane 2-isopropoxy-[1,3,2]oxazaphosphinane 2-sulfide 2-thioxo-2λ5-[1,3,2]oxazaphosphinan-2-ylamine (2R,3S,5S)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane 2-propoxy-[1,3,2]oxazaphosphinane 2-(diethylthiocarbamoylthio)-3-phenyl-1,3,2-oxazaphospholidine